Next |
home / stock / halo / halo message board
Subject | By | Source | When |
---|---|---|---|
Addendum: Should the temptation arise, kindly forgo enlightening me | easycomeandgo | investorshub | 04/30/2023 2:11:01 PM |
It is high time for me to (do | easycomeandgo | investorshub | 04/30/2023 1:57:44 PM |
I am not sure what it will take | easycomeandgo | investorshub | 04/28/2023 2:20:54 PM |
By the way, it was the last CFO | Fred Kadiddlehopper | investorshub | 04/28/2023 1:49:36 PM |
Yes, the efgartigimod delay was noted here; not | Fred Kadiddlehopper | investorshub | 04/28/2023 1:44:49 PM |
Agree. Just saw an article by a reporter for | OncoJock | investorshub | 04/28/2023 1:24:33 PM |
Agree with you Maumar about how well this | OncoJock | investorshub | 04/28/2023 1:13:35 PM |
The deal offers no immediate prospects for future | Fred Kadiddlehopper | investorshub | 04/28/2023 12:47:11 PM |
Glad to hear I'm not the only one | OncoJock | investorshub | 04/28/2023 12:41:11 PM |
This is interesting, thanks for posting. | OncoJock | investorshub | 04/28/2023 12:34:34 PM |
argenx and Genmab Enter Partnership to Advance Antibody | Fred Kadiddlehopper | investorshub | 04/17/2023 1:45:00 PM |
Got it. Thanks so much. My | halofan | investorshub | 04/15/2023 1:05:38 AM |
Page 29 on the March Corporate presentation: One ENHANZE One | biotechinvestor1 | investorshub | 04/15/2023 12:31:00 AM |
I looked back at the PR for the | halofan | investorshub | 04/14/2023 11:45:21 PM |
Right, the option activity is nil but I'm | Fred Kadiddlehopper | investorshub | 04/13/2023 9:02:44 PM |
Today the xbi is up almost 5% and | maumar | investorshub | 04/13/2023 7:37:01 PM |
As you could suppose, I am defensive. As | easycomeandgo | investorshub | 04/13/2023 6:34:51 PM |
What else are you looking at in regard | Fred Kadiddlehopper | investorshub | 04/13/2023 2:05:37 AM |
I fear I did not answer your question. | easycomeandgo | investorshub | 04/12/2023 7:40:00 PM |
Fine, no problem. You are not going to | easycomeandgo | investorshub | 04/12/2023 5:17:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
Halozyme to Report Second Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO , July 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2024 financial and operating re...
2024-07-22 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...